Everything about Healthcare News
Novo CEO pressed by Senate to chop prices of obesity, diabetes medicines CEO Lars Fruergaard Jørgensen informed lawmakers the organization would take into consideration new talks with insurers concerning the listing price ranges of Wegovy and copyright should they pledge to keep the medicines on their own formularies.Insurers will keep on vertical